NK-1 Antagonism of SLV317 in Humans
NCT00160862
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Healthy
Interventions
DRUG:
SLV317
Sponsor
Heidelberg University